{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:07:15Z","timestamp":1787317635425,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2019,11,5]]},"abstract":"<jats:sec xml:lang=\"en\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Predicting clinical outcomes after cardiac resynchronization therapy (\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      ) and its optimization remain a challenge. We sought to determine whether pre\u2010 and postimplantation\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      area (\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      ) predict clinical outcomes after\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      In this retrospective study,\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      , derived from pre\u2010 and postimplantation vectorcardiography, were assessed in relation to the primary end point of cardiac mortality after\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      with or without defibrillation. Other end points included total mortality, total mortality or heart failure (\n                      <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n                      ) hospitalization, total mortality or major adverse cardiac events, and the arrhythmic end point of sudden cardiac death or ventricular arrhythmias with or without a shock. In patients (n=380, age 72.0\u00b112.4\u00a0years, 68.7% male) undergoing\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      over 7.7\u00a0years (median follow\u2010up: 3.8\u00a0years [interquartile range 2.3\u20135.3]), preimplantation\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      \u2265102\u00a0\u03bcVs predicted cardiac mortality (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.36;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001), independent of\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      duration (\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      d) and morphology (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001). A\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      reduction \u226545\u00a0\u03bcVs after\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      predicted cardiac mortality (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.19), total mortality (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.50), total mortality or heart failure hospitalization (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.44), total mortality or major adverse cardiac events (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.43) (all\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001) and the arrhythmic end point (\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.26;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001). A concomitant reduction in\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      and\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      d was associated with the lowest risk of cardiac mortality and the arrhythmic end point (both\n                      <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n                      : 0.12,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Pre\u2010implantation\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      , derived from vectorcardiography, was superior to\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      d and\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      morphology in predicting cardiac mortality after\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      . A postimplant reduction in both\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      <jats:sub>area<\/jats:sub>\n                      and\n                      <jats:styled-content style=\"fixed-case\">QRS<\/jats:styled-content>\n                      d was associated with the best outcomes, including the arrhythmic end point.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/jaha.119.013539","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T05:06:14Z","timestamp":1572239174000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias"],"prefix":"10.1161","volume":"8","author":[{"given":"Osita","family":"Okafor","sequence":"first","affiliation":[{"name":"Aston Medical Research Institute Aston Medical School Aston University Birmingham United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbasin","family":"Zegard","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute Aston Medical School Aston University Birmingham United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Dam","sequence":"additional","affiliation":[{"name":"PEACS Arnhem The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Stegemann","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute Aston Medical School Aston University Birmingham United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Qiu","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute Aston Medical School Aston University Birmingham United Kingdom"},{"name":"Queen Elizabeth Hospital Birmingham United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Marshall","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital Birmingham United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Leyva","sequence":"additional","affiliation":[{"name":"Aston Medical Research Institute Aston Medical School Aston University Birmingham United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.06.1178"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.910778"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2017.08.005"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.743120"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euy254"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2018.10.019"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.07.033"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.13132"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.13241"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2014.10.003"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006497"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2018.08.028"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/14.10.607"},{"key":"e_1_3_1_15_2","unstructured":"National Institute of Health and Care Excellence . NICE technology appraisal [TA 314]: implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120). 2014. London United Kingdom. Available at: https:\/\/www.nice.org.uk\/guidance\/ta314. Accessed February 1 2019."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008508"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.055"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90579-1"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4509"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050496"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906431"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.960898"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.071"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2012.12.003"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.097709"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.894774"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut049"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.956011"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009540"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/pace.13104"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.07.060"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.025577"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp321"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.12.031"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2016.11.019"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eup001"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.119.013539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:30:35Z","timestamp":1715585435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.119.013539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":36,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2019,11,5]]}},"alternative-id":["10.1161\/JAHA.119.013539"],"URL":"https:\/\/doi.org\/10.1161\/jaha.119.013539","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"2019-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e013539"}}